|
|
Volumn 2, Issue 4, 2000, Pages 330-336
|
|
Use of biologics in the treatment of childhood rheumatic diseases.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRHEUMATIC AGENT;
GAMMA INTERFERON;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENT;
INTERLEUKIN 1;
INTERLEUKIN 10;
INTERLEUKIN 11;
INTERLEUKIN 4;
INTERLEUKIN 6;
MONOCLONAL ANTIBODY;
NONSTEROID ANTIINFLAMMATORY AGENT;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR RECEPTOR;
ADULT;
AGE;
CHILD;
CLINICAL TRIAL;
FORECASTING;
HUMAN;
IMMUNOLOGY;
JUVENILE RHEUMATOID ARTHRITIS;
REVIEW;
RHEUMATOID ARTHRITIS;
ADULT;
AGE FACTORS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, JUVENILE RHEUMATOID;
ARTHRITIS, RHEUMATOID;
CHILD;
CLINICAL TRIALS;
FORECASTING;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
INTERFERON TYPE II;
INTERLEUKIN-1;
INTERLEUKIN-10;
INTERLEUKIN-11;
INTERLEUKIN-4;
INTERLEUKIN-6;
RECEPTORS, TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 0034251695
PISSN: 15233774
EISSN: None
Source Type: Journal
DOI: 10.1007/s11926-000-0071-1 Document Type: Review |
|
Times cited : (4)
|
|
References (53)
|
